CDSCO Panel Recommends Approval for Vorasidenib with Phase-III Waiver, Mandates Phase-IV Trial in India Dr. Divya Colin3 Aug 2025 12:00 PM ISTNew Delhi: In response to a proposal by Servier India Pvt. Ltd. seeking approval to import and market the anti-cancer drug Vorasidenib Tablets 10 mg...
SIL declares profit from operations growth as +6% vs previous year Ruchika Sharma3 Aug 2025 11:30 AM ISTMumbai: Sanofi India Limited has announced its financial results for the quarter ended June 30, 2025.The Company recorded a 9% decline in net...
Novartis Told to Revise Protocol, Justify Sample Size in ITU512 Clinical Trial Proposal Parthika Patel3 Aug 2025 9:30 AM ISTNew Delhi: Novartis Healthcare Private Limited has been directed by the Subject Expert Committee (SEC) functional under the Central Drugs Standard...
Biodeal Told To Justify Novel Delivery Claim In NPPA Exemption Plea For Midazolam Nasal Spray Parthika Patel2 Aug 2025 4:51 PM ISTNew Delhi: Biodeal Pharmaceuticals Limited has been directed by the National Pharmaceutical Pricing Authority (NPPA) to submit documents supporting...
CDSCO Panel Accepts Phase I Trial Data for Intas' Denosumab Biosimilar Parthika Patel2 Aug 2025 4:40 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Analgesic and Rheumatology division of the Central Drugs Standard Control Organisation (CDSCO)...
Torrent Pharma: USFDA concludes inspection at Vizag facility with zero observations Ruchika Sharma2 Aug 2025 3:38 PM ISTAhmedabad: Torrent Pharma has announced that the U.S. Food and Drug Administration (USFDA) has concluded an inspection at the company's...
Meril names Faisal Shah Mohammad as Business Head - Neurovascular Ruchika Sharma2 Aug 2025 2:56 PM ISTMeril has named Faisal Shah Mohammad as Business Head - Neurovascular, based in Delhi."We are pleased to welcome Faisal Shah Mohammad as Business...
Gilead Sciences gets USFDA nod for new Biktarvy indication for people with HIV who are treatment experienced, restarting antiretroviral treatment Ruchika Sharma2 Aug 2025 12:30 PM ISTFoster City: Gilead Sciences, Inc. has announced that it has received new approval from the U.S. Food and Drug Administration (FDA) for a...
USFDA issues 4 observations for Jubilant Generics Roorkee facility Ruchika Sharma2 Aug 2025 11:27 AM ISTNoida: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has issued 4 observations at the conclusion...
Granules India arm gets 1 USFDA observation for Hyderabad facility Ruchika Sharma1 Aug 2025 5:45 PM ISTHyderabad: Granules India has announced that the U.S. Food and Drug Administration (USFDA) has issued one observation for the facility of...
CDSCO Panel Clears PURE & CURE's Sickle Cell Trial With Conditions On Sample Size, Sites Parthika Patel1 Aug 2025 5:09 PM ISTNew Delhi: PURE & CURE Healthcare Pvt. Ltd. has received a recommendation from the Subject Expert Committee (SEC) under the Central Drugs Standard...
Sun Pharma net profit drops 20% to Rs 2,279 crore in Q1 Ruchika Sharma1 Aug 2025 4:38 PM ISTMumbai: Drugmaker Sun Pharmaceutical Industries reported a 20 percent year-on-year decline in consolidated net profit to Rs 2,279 crore for the...
